Trial Profile
An Open Label, Prospective and Multi-Center Recurrence Prevention Study With Effexor XR in MDD Patients in China
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2021
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Pfizer; Wyeth
- 21 Sep 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 16 Apr 2009 New trial record